Cohance Lifesciences Limited has announced the grant of a significant number of employee stock options. A total of 69,028 options were granted under the “ESOP 2026” plan, and another 1,03,542 options were granted under the “ESOP 2023” plan. Additionally, the company approved the allotment of 25,600 equity shares upon the exercise of vested options from the ESOP 2023. These grants and allotments are subject to regulatory approvals and terms outlined in the respective option plans.
Employee Stock Option Grants Approved
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, has announced significant grants of employee stock options following a meeting of its Nomination and Remuneration Committee on November 6, 2026. The committee approved the grant of 69,028 stock options under the Cohance Lifesciences Limited – Employee Stock Option Plan 2026 (ESOP 2026). In parallel, 1,03,542 stock options were granted under the Suven Pharmaceuticals Limited – Employee Stock Option Plan 2023 (ESOP 2023).
Allotment of Equity Shares
Further to these grants, the company also approved the allotment of 25,600 equity shares of face value INR 1 each, fully paid-up. These shares are being issued to option grantees who have exercised vested options under the ESOP 2023. Detailed information regarding these grants and allotments, as per SEBI regulations, is provided in the accompanying annexures.
ESOP 2026 Details
The ESOP 2026 provides for the grant of employee stock options that are convertible into equity shares of the company. The total number of shares covered by these options amounts to 69,028. The exercise price for these options will be determined by the Board or the Nomination and Remuneration Committee. Key provisions include an exercise price not less than INR 325 for grants made within six months of exchange approval, or a price not more than a 20% discount to the market price for grants made later. Vesting periods range from a minimum of one year to a maximum of eight years from the grant date.
ESOP 2023 Details
Under the ESOP 2023, 1,03,542 employee stock options have been granted. These options are also convertible into equity shares of the company. The exercise price for all options granted under this plan was set at INR 495. Vesting periods for these options are between a minimum of one year and a maximum of ten years from the grant date.
Share Allotment Specifics
The allotment of 25,600 equity shares, with a face value of INR 1 each, is a direct result of the exercise of vested options under the ESOP 2023. These shares were allotted on November 6, 2026, and carry a distinct number range from 38,25,97,331 to 38,26,22,930. The exercise price per share for these allotted shares was INR 268, with a premium of INR 267 per share. The total issued shares after this allotment stand at 38,26,22,930, and these shares rank pari passu with existing equity shares of the Company.
Source: BSE
